Also listed on Synarc Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 27, 2028 · High confidence
20-year base term ended Sep 4, 2026
Held by Bioclinica, Inc.
Filed Mar 12, 2009 as application 12/083,800 · Granted Oct 2, 2012
Base term plus 815 days of patent term adjustment (USPTO delay)
Today
2006
2028
Clock starts
Sep 4, 2006
Sep 4, 2006
Term ends
Nov 27, 2028
Nov 27, 2028
Granted
Oct 2, 2012
Oct 2, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
815
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 815 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 4, 2006, when application PCT/EP2006/008606, the earliest non-provisional in its chain, was filed (this one was filed Mar 12, 2009) | Sep 4, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +815 days, USPTO patent term adjustment record | Nov 27, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 27, 2028 | High confidence |
This family
| US 8,280,126 | this patent Nov 2028 | Nov 2028 |
1 of 2 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 24, 2009 Reel 22299, frame 325 | Nordic Bioscience A/S | Nordic Bioscience Imaging A/S | Assignment of Assignor's Interest |
| Mar 12, 2009 Reel 22382, frame 131 | Dam, Erik B.; Folkesson, Jenny; Petterson, Paola; Olsen, Ole F.; Nielsen, Mads; Christiansen, Claus | Nordic Bioscience A/S | Assignment of Assignor's Interest |
| Aug 3, 2011 Reel 26693, frame 479 | Nordic Bioscience Imaging A/S, A.K.A. Synarc Imaging Technologies A/S | Synarc Inc. | Assignment of Assignor's Interest |
| Nov 28, 2011 Reel 27282, frame 959 | Synarc Inc. | Bank of America, N.A., as Administrative Agent | Security Agreement |
| Apr 5, 2013 Reel 30157, frame 547 | Synarc Inc. | Bank of America, N.A., as Administrative Agent | Notice of Security Interest in Patents |
| Apr 8, 2013 Reel 30173, frame 902 | Bank of America, N.A., as Administrative Agent | Synarc Inc. | Termination and Release of Security Interest in U.S. Patents (REEL 027282, Frame 0959) |
| Apr 28, 2014 Reel 32776, frame 402 | Bank Of America, N.a. | Synarc Inc. | Termination and Release of Security Interest in United States Patents (Releases Reel 030157 Frame 0547) |
| Apr 28, 2014 Reel 32776, frame 798 | Synarc Inc. | Credit Suisse AG, as First Lien Collateral Agent | Patent Security Agreement (First Lien) |
| Apr 28, 2014 Reel 32777, frame 66 | Synarc Inc. | Credit Suisse AG, as Second Lien Collateral Agent | Patent Security Agreement (Second Lien) |
| Sep 18, 2015 Reel 36596, frame 889 | Bioclinica, Inc.; Synarc Inc. | The Bank of New York Mellon, as Collateral Agent | Security Interest |
| Oct 21, 2016 Reel 40085, frame 965 | Bank of New York Mellon | Bioclinica, Inc.; Synarc Inc. | Release of Security Interest |
| Oct 21, 2016 Reel 40458, frame 800 | Bioclinica, Inc.; Synarc Inc. | Jefferies Finance LLC | First Lien Security Agreement |
| Oct 21, 2016 Reel 40458, frame 810 | Bioclinica, Inc.; Synarc Inc. | Jefferies Finance LLC | Patent Security Agreement |
| Oct 21, 2016 Reel 40458, frame 849 | Credit Suisse AG, Cayman Islands Branch | Bioclinica, Inc.; Synarc, Inc. | Release of Second Lien Security |
| Oct 21, 2016 Reel 40458, frame 915 | Credit Suisse AG, Cayman Islands Branch | Bioclinica, Inc.; Synarc, Inc. | Release of First Lien Security |
| Oct 21, 2016 reel/frame not recorded | Bank of New York Mellon | Bioclinica, Inc. | Release of Security Interest |
| Oct 21, 2016 reel/frame not recorded | Bank of New York Mellon | Synarc Inc. | Release of Security Interest |
| Oct 21, 2016 reel/frame not recorded | Credit Suisse AG, Cayman Islands Branch | Bioclinica, Inc. | Release of Second Lien Security |
| Oct 21, 2016 reel/frame not recorded | Credit Suisse AG, Cayman Islands Branch | Synarc, Inc. | Release of Second Lien Security |
| Oct 21, 2016 reel/frame not recorded | Credit Suisse AG, Cayman Islands Branch | Bioclinica, Inc. | Release of First Lien Security |
| Oct 21, 2016 reel/frame not recorded | Credit Suisse AG, Cayman Islands Branch | Synarc, Inc. | Release of First Lien Security |
| Feb 28, 2019 Reel 48468, frame 743 | Synarc Inc. | Bioclinica, Inc. | Assignment of Assignor's Interest |
| Apr 27, 2021 Reel 56064, frame 341 | Jefferies Finance LLC, as Collateral Agent | Bioclinica, Inc. | First Lien Release of Security Interest in Patents |
| Apr 27, 2021 Reel 56064, frame 563 | Jefferies Finance LLC, as Collateral Agent | Bioclinica, Inc. | Second Lien Release of Security Interest in Patents |
| Mar 21, 2023 Reel 63123, frame 66 | Bioclinica, Inc. | Goldman Sachs Bank USA, as Collateral Agent | First Lien Security Agreement |
| Mar 22, 2023 Reel 63141, frame 589 | Bioclinica, Inc. | Goldman Sachs Bank USA, as Collateral Agent | Second Lien Security Agreement |
| Jan 17, 2025 Reel 69939, frame 325 | Goldman Sachs Bank USA, as Collateral Agent | Bioclinica, Inc. | Release of Security Interest at Reel/Frame 063123/0066 |
| Jan 17, 2025 Reel 69939, frame 414 | Goldman Sachs Bank USA, as Collateral Agent | Bioclinica, Inc. | Release of Security Interest at Reel/Frame 063141/0589 |
| Jan 17, 2025 Reel 69939, frame 472 | Bioclinica, Inc.; Eresearchtechnology, Inc. | Alter Domus (US) LLC, as Collateral Agent | Security Agreement |
| Mar 24, 2026 Reel 75224, frame 52 | Alter Domus (US) LLC | Eresearchtechnology, Inc.; Bioclinica, Inc. | Release of Security Interest in Intellectual Property Recorded at Reel 069939 and Frame 0472 |
| Mar 24, 2026 reel/frame not recorded | Alter Domus (US) LLC | Eresearchtechnology, Inc. | Release of Security Interest in Intellectual Property Recorded at Reel 069939 and Frame 0472 |
| Mar 24, 2026 reel/frame not recorded | Alter Domus (US) LLC | Bioclinica, Inc. | Release of Security Interest in Intellectual Property Recorded at Reel 069939 and Frame 0472 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2028
Term ends Nov 27, 2028. No further fees fall due before then
Note
The 815 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
42
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.